241468 ⎘
Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy
SYSTEMS AND METHODS FOR IMPROVED IN VIVO ANALYTE SENSOR FUNCTION
#2MEASURING CIRCULATING THERAPEUTIC ANTIBODY, ANTIGEN AND ANTIGEN/ANTIBODY COMPLEXES USING ELISA ASSAYS
#3TREATMENT OF AUTOIMMUNE DISEASES
#4Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
#5Treatment of pemphigus
#6Method for altering the binding specificity of plasma proteins by oxidation
#7IgE CH3 peptide vaccine
#8Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
#9Methods for treating chronic obstructive pulmonary disease
#10C(epsilon)mX peptides for inducing immune responses to human mIgE on B lymphocytes
#11Anti-CεmX antibodies capable of binding to human mIgE on B lymphocytes
#12Methods of treating autoimmune diseases with anti-FcεRI antibodies
#13Methods, compositions and kits relating to chitnases and chitnase-like molecules and inflammation disease
#14Method of altering the binding specificity of plasma proteins by oxidation-reduction
#15Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
#16Human antibodies that bind human TNFα
#17Human antibodies that bind human TNFα
#18Anti-CεmX antibodies capable of binding to human mIgE on B lymphocytes
#19TREATMENT OF MULTIPLE SCLEROSIS
#20Human antibodies that bind human TNFα and methods of using same
#21Drug delivery system
#22METHOD TO INHIBIT AIRWAY HYPERRESPONSIVENESS USING AEROSOLIZED T CELL RECEPTOR ANTIBODIES
#23Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
#24Methods for treating chronic obstructive pulmonary disease
#25Methods for treating IgE-mediated disorder
#26Olopatadine formulations for topical nasal administration
#27IgE CH3 peptide vaccine
#28Method for diagnosing auto-immune chronic urticaria
#29Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
#30Method for the detection of endometriosis using an ME-2 antigen
#31Methods and compositions for inhibiting binding of IgE to a high affinity receptor
#32METHOD OF TREATING IMMUNE DISEASE USING B-CELL ANTIBODIES
#33Treatment of Autoimmune Diseases
#34Treatment of vasculitis
#35Treatment of Autoimmune Diseases
#36Treatment of Autoimmune Diseases
#37Method of detecting endometriosis in human subjects using SEQ ID No. 9 or an epitope thereof
#38Method of treating or preventing a disease or condition mediated by pathogenic IgG antibodies
#39Treatment of autoimmune conditions with Copolymer 1 and related copolymers
#40BoNT/A Peptides and Methods of Predicting and Reducing Immunoresistance to Botulinum Toxin Therapy
#41Bont/a peptides and methodsof predicting and reducing immunoresistance to botulinum toxin therapy
#42METHODS AND COMPOSITIONS FOR DETECTION AND DIAGNOSIS OF INFECTIOUS DISEASES
#43Methods for treating Chronic Obstructive Pulmonary Disease
#44Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
#45Diagnosis of fasciolosis by skin test (intradermoreaction) using the antigen Fh8 (fasciolin)
#46Binding members for IgE molecules
#47Methods and compositions for inhibiting binding of IgE to a high affinity receptor
#48Process for preparing hypoallergenic and reduced fat foods
#49Methods of diagnosing endometriosis in human subjects using the ME-5 polypeptide
#50Methods of treating disorders using human antibodies that bind human TNFα
#51Human antibodies that bind human TNFα
#52Aptameric IgE peptides in a protein scaffold as an allergy vaccine
#53Methods to treating chronic obstructive pulmonary disease
#54METHODS, COMPOSITIONS, AND KITS RELATING TO CHITINASES AND CHITINASE-LIKE MOLECULES AND INFLAMMATORY DISEASE
#55Methods for treating rheumatoid arthritis using human antibodies that bind human TNFa
#56Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory disease
#57Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory disease
#58Allo and Auto-Reactive T-Cell Epitopes
#59Methods for diagnosing auto-immune chronic urticaria
#60Binding members for IgE molecules
#61Allergy vaccines and their preparation
#62Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions
#63Non-anaphylactic forms of grass pollen Ph1 p 6 allergen and their use
#64ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis
#65Methods for treating rheumatoid arthritis using human antibodies that bind human TNFα
#66BoNT/A peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy
#67ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis
#68BoNT/A peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy
#69BoNT/A peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy
#70Olopatadine formulations for topical nasal administration
#71ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis
#72Treatment of autoimmune conditions with Copolymer 1 and related Copolymers
#73Receptor specific transepithelial transport of therapeutics
#74Process for preparing hypoallergenic and reduced fat foods
#75Method for treating established spontaneous auto-immune diseases in mammals
#76Polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use
#77Use of heparinases to decrease inflammatory response
#78Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions
#79Method of affecting a function of or ablating a non-malignant cell
#80Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
#81Notch
#82Human antibodies that bind human TNFα
#83ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis
#84Polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use
#85Methods for the treatment of inflammatory joint disease
#86Treatment of complement-associated disorders
#87Use of heparinase to decrease inflammatory responses
#88Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule
#89Methods and compositions for detection and diagnosis of infectious diseases
#90Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions
#91Suppression of immune response via inhibition of cathepsin S
#92Suppression of immune response via inhibition of cathepsin S
#93MHC class II antigen-presenting systems and methods for activating CD4T cells
#94MHC class II antigen-presenting systems and methods for activating CD4T cells
#95Antibodies to cytokines in the prevention and treatment of inflammatory bowel disease
#96Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule
#97Epsigam fusion protein
#98Epsigam fusion protein